Getting your player ready...
Denver-based ValveXchange Inc. has received a $3.5 million equity investment from a Georgia-based tissue-processing and medical device company focused on cardiac and vascular surgery.
ValveXchange is a private medical device company that was spun-off out of Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets.
Under the agreement, CryoLife will receive about 19 percent equity ownership in ValveXchange as well as the right of first refusal to acquire ValveXchange.
